Since ATF4 protein expression is known to be activated through phosphorylation of eIF2α, we examined eIF2α phosphorylation levels after Sunitinib treatment in a number of BTICs and glioblastoma cell lines (Figure 3B). This evidence concerns the gene ATF4 and glioblastoma.